2.21
0.91%
+0.02
Pre-market:
2.28
0.07
+3.17%
Accuray Inc stock is currently priced at $2.21, with a 24-hour trading volume of 683.35K.
It has seen a +0.91% increased in the last 24 hours and a -14.01% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $2.20 pivot point. If it approaches the $2.24 resistance level, significant changes may occur.
Accuray Inc Stock (ARAY) Financials Data
Accuray Inc (ARAY) Revenue 2024
ARAY reported a revenue (TTM) of $447.48 million for the quarter ending December 31, 2023, a +7.20% rise year-over-year.
Accuray Inc (ARAY) Net Income 2024
ARAY net income (TTM) was -$14.55 million for the quarter ending December 31, 2023, a -23.06% decrease year-over-year.
Accuray Inc (ARAY) Cash Flow 2024
ARAY recorded a free cash flow (TTM) of $7.61 million for the quarter ending December 31, 2023, a +115.32% increase year-over-year.
Accuray Inc (ARAY) Earnings per Share 2024
ARAY earnings per share (TTM) was -$0.15 for the quarter ending December 31, 2023, a -15.38% decline year-over-year.
Accuray Inc Stock (ARAY) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Corradetti GIna | VP, CAO and Controller |
Jan 03 '24 |
Sale |
2.74 |
14,129 |
38,729 |
196,138 |
Pervaiz Ali | SVP Chief Financial Officer |
Jan 03 '24 |
Sale |
2.74 |
2,116 |
5,800 |
402,743 |
Winter Suzanne C | President |
Dec 01 '23 |
Sale |
2.47 |
65,390 |
161,624 |
1,369,811 |
Chew Jesse | SVP, General Counsel |
Dec 01 '23 |
Sale |
2.47 |
29,770 |
73,565 |
381,920 |
Hoge Michael | Senior VP Global Operations |
Dec 01 '23 |
Sale |
2.47 |
19,212 |
47,482 |
402,199 |
Spine Patrick | SVP, Chief Admin Officer |
Dec 01 '23 |
Sale |
2.47 |
14,832 |
36,653 |
219,484 |
Chalke Sandeep | SVP, Chief Commercial Officer |
Dec 01 '23 |
Sale |
2.47 |
14,585 |
36,041 |
555,640 |
Pervaiz Ali | SVP Chief Financial Officer |
Dec 01 '23 |
Sale |
2.47 |
13,463 |
33,271 |
404,859 |
Winter Suzanne C | President |
Nov 01 '23 |
Sale |
2.57 |
38,338 |
98,529 |
1,436,616 |
Pervaiz Ali | SVP Chief Financial Officer |
Oct 31 '23 |
Sale |
2.58 |
3,303 |
8,534 |
401,857 |
Accuray Inc Stock (ARAY) Latest News
Atossa (ATOS) Reports Positive Results From EVANGELINE Study
Zacks Investment Research
Accuray Getting Very Little Love Ahead Of A Coming Revenue Ramp
Seeking Alpha
Accuray's (ARAY) CyberKnife Improves Prostate Cancer Treatment
Zacks Investment Research
Here's Why You Should Retain Accuray (ARAY) Stock for Now
Zacks Investment Research
Accuray (ARAY) Up 1.6% Since Last Earnings Report: Can It Continue?
Zacks Investment Research
Three Reasons to Retain Accuray (ARAY) Stock in Your Portfolio
Zacks Investment Research
About Accuray Inc
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. The CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. It also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. The company markets its products in the United States directly, as well as through a sales agent and group purchasing organizations; and directly and through distributors and sales agents in Europe, Japan and other countries of Asia, South America, and internationally to hospitals and stand-alone treatment facilities. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.
Cap:
|
Volume (24h):